What is Pfizer's other accrued liabilities?

Pfizer (PFE) reported other accrued liabilities of $20.11B in Q1 2026.

How has Pfizer's other accrued liabilities changed year-over-year?

Pfizer's other accrued liabilities increased by 0.5% year-over-year, from $20.02B to $20.11B.

What is the long-term trend for Pfizer's other accrued liabilities?

Over 5 years (2020 to 2025), Pfizer's other accrued liabilities has grown at a 10.9% compound annual growth rate (CAGR), from $11.56B to $19.43B.

Pfizer PFE Other accrued liabilities

Other accrued liabilities at other companies

Bristol-Myers SquibbBMY

$12.62B-23.6%

Eli LillyLLY

——

Merck & Co.MRK

——

IncyteINCY

——

ModernaMRNA

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+5.0%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$143.68B+11.1%

Enterprise value$206.35B+9.2%

P/E11.9×—

P/S2.3×+0.2×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's other accrued liabilities?: Pfizer (PFE) reported other accrued liabilities of $20.11B in Q1 2026.
How has Pfizer's other accrued liabilities changed year-over-year?: Pfizer's other accrued liabilities increased by 0.5% year-over-year, from $20.02B to $20.11B.
What is the long-term trend for Pfizer's other accrued liabilities?: Over 5 years (2020 to 2025), Pfizer's other accrued liabilities has grown at a 10.9% compound annual growth rate (CAGR), from $11.56B to $19.43B.